Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postmenopausal Women With Osteoporosis at High Risk of Fracture”

11 trials

Showing 11 of 11 results

Large-scale testing (Phase 3)Study completedNCT07028320
What this trial is testing

To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk

Who this might be right for
Postmenopausal Women With Osteoporosis
Shenzhen Salubris Pharmaceuticals Co., Ltd. 493
Large-scale testing (Phase 3)UnknownNCT05060406
What this trial is testing

Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture

Who this might be right for
Postmenopausal Osteoporosis
Luye Pharma Group Ltd. 448
Early research (Phase 1)Active Not RecruitingNCT06949137
What this trial is testing

Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture

Who this might be right for
Osteoporosis in Post-menopausal WomenOsteoporosis
HELP Therapeutics Co., Ltd. 9
Large-scale testing (Phase 3)UnknownNCT04128163
What this trial is testing

Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk

Who this might be right for
Postmenopausal Osteoporosis
Qilu Pharmaceutical Co., Ltd. 440
Post-approval studies (Phase 4)Study completedNCT06079476
What this trial is testing

Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.

Who this might be right for
Postmenopausal Osteoporosis
Amgen 100
Testing effectiveness (Phase 2)Looking for participantsNCT07579936
What this trial is testing

A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens

Who this might be right for
Postmenopausal Women With Osteoporosis
Shenzhen Salubris Pharmaceuticals Co., Ltd. 200
Large-scale testing (Phase 3)Study completedNCT05352516
What this trial is testing

Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

Who this might be right for
Postmenopausal
Shanghai Henlius Biotech 514
Large-scale testing (Phase 3)Looking for participantsNCT07062978
What this trial is testing

A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®

Who this might be right for
Postmenopausal Women With Osteoporosis at High Risk of Fracture
Qilu Pharmaceutical Co., Ltd. 278
Post-approval studies (Phase 4)Not Yet RecruitingNCT07772609
What this trial is testing

Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD

Who this might be right for
Osteoporosis in Post-menopausal Women
Sahlgrenska University Hospital 216
Large-scale testing (Phase 3)Study completedNCT04591275
What this trial is testing

Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® .

Who this might be right for
Postmenopausal Osteoporosis
Shanghai Biomabs Pharmaceutical Co., Ltd. 278
Large-scale testing (Phase 3)Not Yet RecruitingNCT06898060
What this trial is testing

To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture

Who this might be right for
Postmenopausal Women With Osteoporosis
Qilu Pharmaceutical Co., Ltd. 282

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation